Mary E Klotman, MD

Professor of Medicine
R.J. Reynolds Professor of Medicine
Dean, School of Medicine
Professor in Molecular Genetics and Microbiology
Professor of Pathology
Member of the Duke Human Vaccine Institute
Campus mail DUMC 2927, Davison Building Room 125, Durham, NC 27710
Phone (919) 684-2455
Email address mary.klotman@duke.edu

Dr. Klotman became dean of the Duke School of Medicine in June 2017.

An accomplished clinician and scientist, Klotman’s research interests are focused on the molecular pathogenesis of Human Immunodeficiency Virus 1 (HIV-1) infection.

Among many important contributions to this field, Klotman and her team demonstrated that HIV resides in and evolves separately in kidney cells, a critical step in HIV-associated kidney disease. Her research group also has determined the role of soluble host factors involved in an innate immune response to HIV in an effort to improve prevention strategies, topical microbicides that could be used to block sexual transmission of HIV.

Most recently, her group has been defining the role of integrase-defective lentiviral vectors for the delivery of an HIV vaccine. (Read the announcement.)

In Their Words

Education and Training

  • Fellow in Infectious Diseases, Medicine, Duke University, 1983 - 1985
  • Resident, Medicine, Duke University, 1980 - 1983
  • M.D., Duke University, 1980

Publications

He, John Cijiang, Mohammad Husain, Masaaki Sunamoto, Vivette D. D’Agati, Mary E. Klotman, Ravi Iyengar, and Paul E. Klotman. “Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways..” The Journal of Clinical Investigation 114, no. 5 (September 2004): 643–51. https://doi.org/10.1172/JCI200421004.

Full Text

He, John Cijiang, Mohammad Husain, Masaaki Sunamoto, Vivette D. D’Agati, Mary E. Klotman, Ravi Iyengar, and Paul E. Klotman. “Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways..” J Clin Invest 114, no. 5 (September 2004): 643–51. https://doi.org/10.1172/JCI21004.

PMID
15343382
Full Text

Chang, Theresa L., and Mary E. Klotman. “Defensins: natural anti-HIV peptides..” Aids Rev 6, no. 3 (July 2004): 161–68.

PMID
15595433
Scholars@Duke

Cheshenko, Natalia, Marla J. Keller, Veronica MasCasullo, Gary A. Jarvis, Hui Cheng, Minnie John, Jin-Hua Li, et al. “Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread..” Antimicrob Agents Chemother 48, no. 6 (June 2004): 2025–36. https://doi.org/10.1128/AAC.48.6.2025-2036.2004.

PMID
15155195
Full Text

Vargas, J., G. L. Gusella, V. Najfeld, M. E. Klotman, and A. Cara. “Novel integrase-defective lentiviral episomal vectors for gene transfer..” Hum Gene Ther 15, no. 4 (April 2004): 361–72. https://doi.org/10.1089/104303404322959515.

PMID
15053861
Full Text

Zerhouni-Layachi, B., D. Marras, F. Francois, P. E. Klotman, and M. E. Klotman. “Phenotypic characterization of HIV-1 envelopes derived from patients with HIVAN..” In Journal of the American Society of Nephrology, 14:154A-154A. LIPPINCOTT WILLIAMS & WILKINS, 2003.

Scholars@Duke

Ross, Michael D., Leslie A. Bruggeman, Basil Hanss, Masaaki Sunamoto, Daniele Marras, Mary E. Klotman, and Paul E. Klotman. “Podocan, a novel small leucine-rich repeat protein expressed in the sclerotic glomerular lesion of experimental HIV-associated nephropathy..” J Biol Chem 278, no. 35 (August 29, 2003): 33248–55. https://doi.org/10.1074/jbc.M301299200.

PMID
12796502
Full Text

Chang, Theresa Li-Yun, Fleur François, Arevik Mosoian, and Mary E. Klotman. “CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition..” J Virol 77, no. 12 (June 2003): 6777–84. https://doi.org/10.1128/jvi.77.12.6777-6784.2003.

PMID
12767998
Full Text

Keller, Marla J., Mary E. Klotman, and Betsy C. Herold. “Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus..” The Journal of Antimicrobial Chemotherapy 51, no. 5 (May 2003): 1099–1102. https://doi.org/10.1093/jac/dkg214.

PMID
12697652
Full Text

Pages